REGENERON PHARMACEUTICALS, INC. Insider Trading for March 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in REGENERON PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in REGENERON PHARMACEUTICALS, INC. for March 2014.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 31 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 315.33 | 6,393 | 2,015,878 | 20,018,090 | 20 M to 20 M (+0.03 %) |
Mar 31 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 314.38 | 9,278 | 2,916,794 | 20,011,697 | 20 M to 20 M (+0.05 %) |
Mar 31 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 313.42 | 7,481 | 2,344,673 | 20,002,419 | 20 M to 20 M (+0.04 %) |
Mar 31 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 312.31 | 12,670 | 3,956,911 | 19,994,938 | 20 M to 20 M (+0.06 %) |
Mar 31 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 311.19 | 33,203 | 10,332,551 | 19,982,268 | 19.9 M to 20 M (+0.17 %) |
Mar 31 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 310.35 | 33,102 | 10,273,093 | 19,949,065 | 19.9 M to 19.9 M (+0.17 %) |
Mar 31 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 309.19 | 25,893 | 8,005,968 | 19,915,963 | 19.9 M to 19.9 M (+0.13 %) |
Mar 31 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 308.10 | 12,209 | 3,761,581 | 19,890,070 | 19.9 M to 19.9 M (+0.06 %) |
Mar 31 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 307.32 | 10,352 | 3,181,330 | 19,877,861 | 19.9 M to 19.9 M (+0.05 %) |
Mar 31 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 306.21 | 20,264 | 6,205,080 | 19,867,509 | 19.8 M to 19.9 M (+0.10 %) |
Mar 31 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 305.27 | 13,778 | 4,205,992 | 19,847,245 | 19.8 M to 19.8 M (+0.07 %) |
Mar 31 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 304.28 | 15,554 | 4,732,762 | 19,833,467 | 19.8 M to 19.8 M (+0.08 %) |
Mar 31 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 303.19 | 19,390 | 5,878,798 | 19,817,913 | 19.8 M to 19.8 M (+0.10 %) |
Mar 31 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 302.10 | 37,837 | 11,430,372 | 19,798,523 | 19.8 M to 19.8 M (+0.19 %) |
Mar 31 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 301.32 | 30,467 | 9,180,338 | 19,760,686 | 19.7 M to 19.8 M (+0.15 %) |
Mar 31 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 300.28 | 19,074 | 5,727,463 | 19,730,219 | 19.7 M to 19.7 M (+0.10 %) |
Mar 31 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 316.49 | 100 | 31,649 | 19,711,145 | 19.7 M to 19.7 M (0.00 %) |
Mar 31 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 315.44 | 5,654 | 1,783,514 | 19,711,045 | 19.7 M to 19.7 M (+0.03 %) |
Mar 31 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 314.61 | 16,153 | 5,081,844 | 19,705,391 | 19.7 M to 19.7 M (+0.08 %) |
Mar 31 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 313.62 | 20,470 | 6,419,869 | 19,689,238 | 19.7 M to 19.7 M (+0.10 %) |
Mar 31 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 312.56 | 45,235 | 14,138,566 | 19,668,768 | 19.6 M to 19.7 M (+0.23 %) |
Mar 31 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 311.65 | 49,846 | 15,534,715 | 19,623,533 | 19.6 M to 19.6 M (+0.25 %) |
Mar 31 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 310.68 | 61,030 | 18,960,593 | 19,573,687 | 19.5 M to 19.6 M (+0.31 %) |
Mar 31 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 309.79 | 70,552 | 21,856,572 | 19,512,657 | 19.4 M to 19.5 M (+0.36 %) |
Mar 31 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 308.75 | 19,807 | 6,115,318 | 19,442,105 | 19.4 M to 19.4 M (+0.10 %) |
Mar 31 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 307.66 | 4,869 | 1,497,974 | 19,422,298 | 19.4 M to 19.4 M (+0.03 %) |
Mar 31 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 306.53 | 5,845 | 1,791,675 | 19,417,429 | 19.4 M to 19.4 M (+0.03 %) |
Mar 31 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 305.55 | 5,635 | 1,721,796 | 19,411,584 | 19.4 M to 19.4 M (+0.03 %) |
Mar 31 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 302.96 | 1,749 | 529,879 | 19,405,949 | 19.4 M to 19.4 M (+0.01 %) |
Mar 27 2014 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Option Exercise | C | 0.00 | 10,000 | 0 | 20,000 | |
Mar 27 2014 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Buy | C | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Option Exercise | M | 23.84 | 15,000 | 357,600 | 0 | |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 313.40 | 100 | 31,340 | 9,000 | 9.1 K to 9 K (-1.10 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 312.29 | 600 | 187,374 | 9,100 | 9.7 K to 9.1 K (-6.19 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 311.46 | 1,200 | 373,752 | 9,700 | 10.9 K to 9.7 K (-11.01 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 310.80 | 600 | 186,480 | 10,900 | 11.5 K to 10.9 K (-5.22 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 308.25 | 400 | 123,300 | 11,500 | 11.9 K to 11.5 K (-3.36 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 307.65 | 300 | 92,295 | 11,900 | 12.2 K to 11.9 K (-2.46 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 305.25 | 200 | 61,050 | 12,200 | 12.4 K to 12.2 K (-1.61 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 304.42 | 300 | 91,326 | 12,400 | 12.7 K to 12.4 K (-2.36 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 303.64 | 300 | 91,092 | 12,700 | 13 K to 12.7 K (-2.31 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 302.90 | 100 | 30,290 | 13,000 | 13.1 K to 13 K (-0.76 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 301.12 | 700 | 210,784 | 13,100 | 13.8 K to 13.1 K (-5.07 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 300.09 | 10,200 | 3,060,918 | 13,800 | 24 K to 13.8 K (-42.50 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Buy | M | 23.84 | 15,000 | 357,600 | 24,000 | 9 K to 24 K (+166.67 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 314.22 | 3,798 | 1,193,389 | 18,790,310 | 18.8 M to 18.8 M (+0.02 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 313.11 | 11,628 | 3,640,815 | 18,786,512 | 18.8 M to 18.8 M (+0.06 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 312.19 | 17,213 | 5,373,646 | 18,774,884 | 18.8 M to 18.8 M (+0.09 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 311.20 | 36,778 | 11,445,468 | 18,757,671 | 18.7 M to 18.8 M (+0.20 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 310.23 | 36,189 | 11,226,794 | 18,720,893 | 18.7 M to 18.7 M (+0.19 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 309.30 | 20,627 | 6,379,948 | 18,684,704 | 18.7 M to 18.7 M (+0.11 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 308.21 | 24,473 | 7,542,760 | 18,664,077 | 18.6 M to 18.7 M (+0.13 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 307.17 | 32,358 | 9,939,468 | 18,639,604 | 18.6 M to 18.6 M (+0.17 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 306.23 | 45,101 | 13,811,058 | 18,607,246 | 18.6 M to 18.6 M (+0.24 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 305.08 | 39,976 | 12,196,046 | 18,562,145 | 18.5 M to 18.6 M (+0.22 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 304.35 | 22,106 | 6,727,886 | 18,522,169 | 18.5 M to 18.5 M (+0.12 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 303.33 | 6,592 | 1,999,577 | 18,500,063 | 18.5 M to 18.5 M (+0.04 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 302.10 | 1,509 | 455,864 | 18,493,471 | 18.5 M to 18.5 M (+0.01 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 301.24 | 1,582 | 476,560 | 18,491,962 | 18.5 M to 18.5 M (+0.01 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 300.24 | 3,988 | 1,197,358 | 18,490,380 | 18.5 M to 18.5 M (+0.02 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 299.01 | 3,027 | 905,098 | 18,486,392 | 18.5 M to 18.5 M (+0.02 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 332.78 | 1,915 | 637,280 | 18,483,365 | 18.5 M to 18.5 M (+0.01 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 331.49 | 2,110 | 699,447 | 18,481,450 | 18.5 M to 18.5 M (+0.01 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 330.38 | 506 | 167,174 | 18,479,340 | 18.5 M to 18.5 M (0.00 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 329.17 | 1,749 | 575,715 | 18,478,834 | 18.5 M to 18.5 M (+0.01 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 328.22 | 7,476 | 2,453,754 | 18,477,085 | 18.5 M to 18.5 M (+0.04 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 327.04 | 8,918 | 2,916,581 | 18,469,609 | 18.5 M to 18.5 M (+0.05 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 326.11 | 13,905 | 4,534,533 | 18,460,691 | 18.4 M to 18.5 M (+0.08 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 325.19 | 25,116 | 8,167,397 | 18,446,786 | 18.4 M to 18.4 M (+0.14 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 324.09 | 31,754 | 10,291,262 | 18,421,670 | 18.4 M to 18.4 M (+0.17 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 323.32 | 27,688 | 8,952,189 | 18,389,916 | 18.4 M to 18.4 M (+0.15 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 322.28 | 21,101 | 6,800,430 | 18,362,228 | 18.3 M to 18.4 M (+0.12 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 321.23 | 16,036 | 5,151,241 | 18,341,127 | 18.3 M to 18.3 M (+0.09 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 320.09 | 23,411 | 7,493,561 | 18,325,091 | 18.3 M to 18.3 M (+0.13 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 319.19 | 37,436 | 11,948,995 | 18,301,680 | 18.3 M to 18.3 M (+0.20 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 318.36 | 26,229 | 8,350,343 | 18,264,244 | 18.2 M to 18.3 M (+0.14 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 317.23 | 23,644 | 7,500,565 | 18,238,015 | 18.2 M to 18.2 M (+0.13 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 316.16 | 5,700 | 1,802,105 | 18,214,371 | 18.2 M to 18.2 M (+0.03 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 315.07 | 14,463 | 4,556,911 | 18,208,671 | 18.2 M to 18.2 M (+0.08 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 314.21 | 10,934 | 3,435,605 | 18,194,208 | 18.2 M to 18.2 M (+0.06 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 313.12 | 5,024 | 1,573,133 | 18,183,274 | 18.2 M to 18.2 M (+0.03 %) |
Mar 21 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 328.93 | 14,641 | 4,815,879 | 18,178,250 | 18.2 M to 18.2 M (+0.08 %) |
Mar 21 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 328.49 | 35,030 | 11,507,159 | 18,163,609 | 18.1 M to 18.2 M (+0.19 %) |
Mar 21 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 327.52 | 6,142 | 2,011,654 | 18,128,579 | 18.1 M to 18.1 M (+0.03 %) |
Mar 21 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 325.94 | 2,144 | 698,819 | 18,122,437 | 18.1 M to 18.1 M (+0.01 %) |
Mar 21 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 328.67 | 4,571 | 1,502,339 | 18,120,293 | 18.1 M to 18.1 M (+0.03 %) |
Mar 21 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 327.60 | 3,428 | 1,123,021 | 18,115,722 | 18.1 M to 18.1 M (+0.02 %) |
Mar 21 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 326.44 | 1,747 | 570,291 | 18,112,294 | 18.1 M to 18.1 M (+0.01 %) |
Mar 18 2014 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Option Exercise | M | 33.42 | 2,000 | 66,840 | 3,000 | |
Mar 18 2014 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Sell | S | 336.49 | 300 | 100,947 | 14,662 | 15 K to 14.7 K (-2.01 %) |
Mar 18 2014 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Sell | S | 335.69 | 100 | 33,569 | 14,962 | 15.1 K to 15 K (-0.66 %) |
Mar 18 2014 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Sell | S | 334.59 | 500 | 167,295 | 15,062 | 15.6 K to 15.1 K (-3.21 %) |
Mar 18 2014 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Sell | S | 333.42 | 1,100 | 366,762 | 15,562 | 16.7 K to 15.6 K (-6.60 %) |
Mar 18 2014 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Buy | M | 33.42 | 2,000 | 66,840 | 16,662 | 14.7 K to 16.7 K (+13.64 %) |
Mar 18 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 328.86 | 25,629 | 8,428,443 | 18,110,547 | 18.1 M to 18.1 M (+0.14 %) |
Mar 18 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 328.32 | 34,499 | 11,326,791 | 18,084,918 | 18.1 M to 18.1 M (+0.19 %) |
Mar 18 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 329.00 | 8,158 | 2,683,982 | 18,050,419 | 18 M to 18.1 M (+0.05 %) |
Mar 18 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 328.64 | 33,081 | 10,871,776 | 18,042,261 | 18 M to 18 M (+0.18 %) |
Mar 18 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 327.52 | 11,096 | 3,634,105 | 18,009,180 | 18 M to 18 M (+0.06 %) |
Mar 18 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 326.77 | 3,248 | 1,061,351 | 17,998,084 | 18 M to 18 M (+0.02 %) |
Mar 14 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 339.27 | 34,834 | 11,817,995 | 17,994,836 | 18 M to 18 M (+0.19 %) |
Mar 14 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 338.35 | 40,535 | 13,714,871 | 17,960,002 | 17.9 M to 18 M (+0.23 %) |
Mar 14 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 337.41 | 32,539 | 10,979,121 | 17,919,467 | 17.9 M to 17.9 M (+0.18 %) |
Mar 14 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 336.71 | 18,859 | 6,350,006 | 17,886,928 | 17.9 M to 17.9 M (+0.11 %) |
Mar 14 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 335.39 | 10,334 | 3,465,962 | 17,868,069 | 17.9 M to 17.9 M (+0.06 %) |
Mar 14 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 333.84 | 12,594 | 4,204,391 | 17,857,735 | 17.8 M to 17.9 M (+0.07 %) |
Mar 14 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 331.70 | 6,129 | 2,032,986 | 17,845,141 | 17.8 M to 17.8 M (+0.03 %) |
Mar 14 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 330.74 | 20,851 | 6,896,222 | 17,839,012 | 17.8 M to 17.8 M (+0.12 %) |
Mar 14 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 329.33 | 2,600 | 856,246 | 17,818,161 | 17.8 M to 17.8 M (+0.01 %) |
Mar 14 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 328.22 | 11,822 | 3,880,173 | 17,815,561 | 17.8 M to 17.8 M (+0.07 %) |
Mar 14 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 327.49 | 9,819 | 3,215,654 | 17,803,739 | 17.8 M to 17.8 M (+0.06 %) |
Mar 14 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 326.52 | 15,296 | 4,994,389 | 17,793,920 | 17.8 M to 17.8 M (+0.09 %) |
Mar 14 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 325.40 | 4,783 | 1,556,395 | 17,778,624 | 17.8 M to 17.8 M (+0.03 %) |
Mar 12 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 335.68 | 26,830 | 9,006,166 | 17,773,841 | 17.7 M to 17.8 M (+0.15 %) |
Mar 12 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 334.89 | 15,835 | 5,302,978 | 17,747,011 | 17.7 M to 17.7 M (+0.09 %) |
Mar 12 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 333.59 | 19,967 | 6,660,738 | 17,731,176 | 17.7 M to 17.7 M (+0.11 %) |
Mar 12 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 332.50 | 31,603 | 10,507,931 | 17,711,209 | 17.7 M to 17.7 M (+0.18 %) |
Mar 12 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 331.61 | 18,019 | 5,975,288 | 17,679,606 | 17.7 M to 17.7 M (+0.10 %) |
Mar 12 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 330.46 | 31,792 | 10,505,984 | 17,661,587 | 17.6 M to 17.7 M (+0.18 %) |
Mar 12 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 329.68 | 32,976 | 10,871,567 | 17,629,795 | 17.6 M to 17.6 M (+0.19 %) |
Mar 12 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 328.82 | 3,688 | 1,212,683 | 17,596,819 | 17.6 M to 17.6 M (+0.02 %) |
Mar 12 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 332.26 | 2,289 | 760,540 | 17,593,131 | 17.6 M to 17.6 M (+0.01 %) |
Mar 12 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 331.49 | 3,808 | 1,262,330 | 17,590,842 | 17.6 M to 17.6 M (+0.02 %) |
Mar 12 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 330.43 | 44,105 | 14,573,487 | 17,587,034 | 17.5 M to 17.6 M (+0.25 %) |
Mar 12 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 329.26 | 51,909 | 17,091,552 | 17,542,929 | 17.5 M to 17.5 M (+0.30 %) |
Mar 12 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 328.31 | 48,518 | 15,928,891 | 17,491,020 | 17.4 M to 17.5 M (+0.28 %) |
Mar 12 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 327.58 | 22,731 | 7,446,123 | 17,442,502 | 17.4 M to 17.4 M (+0.13 %) |
Mar 12 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 326.43 | 14,124 | 4,610,499 | 17,419,771 | 17.4 M to 17.4 M (+0.08 %) |
Mar 12 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 325.34 | 12,338 | 4,014,013 | 17,405,647 | 17.4 M to 17.4 M (+0.07 %) |
Mar 10 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 339.06 | 100 | 33,906 | 17,393,309 | 17.4 M to 17.4 M (0.00 %) |
Mar 10 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 338.06 | 4,700 | 1,588,900 | 17,393,209 | 17.4 M to 17.4 M (+0.03 %) |
Mar 10 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 337.16 | 5,400 | 1,820,639 | 17,388,509 | 17.4 M to 17.4 M (+0.03 %) |
Mar 10 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 335.85 | 8,951 | 3,006,185 | 17,383,109 | 17.4 M to 17.4 M (+0.05 %) |
Mar 10 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 335.06 | 22,931 | 7,683,254 | 17,374,158 | 17.4 M to 17.4 M (+0.13 %) |
Mar 10 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 334.09 | 23,881 | 7,978,396 | 17,351,227 | 17.3 M to 17.4 M (+0.14 %) |
Mar 10 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 332.84 | 23,743 | 7,902,570 | 17,327,346 | 17.3 M to 17.3 M (+0.14 %) |
Mar 10 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 332.08 | 48,025 | 15,948,166 | 17,303,603 | 17.3 M to 17.3 M (+0.28 %) |
Mar 10 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 331.01 | 95,568 | 31,634,317 | 17,255,578 | 17.2 M to 17.3 M (+0.56 %) |
Mar 10 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 330.16 | 6,219 | 2,053,251 | 17,160,010 | 17.2 M to 17.2 M (+0.04 %) |
Mar 10 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 328.85 | 2,105 | 692,233 | 17,153,791 | 17.2 M to 17.2 M (+0.01 %) |
Mar 10 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 327.77 | 195 | 63,914 | 17,151,686 | 17.2 M to 17.2 M (0.00 %) |
Mar 10 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 325.83 | 241 | 78,524 | 17,151,491 | 17.2 M to 17.2 M (0.00 %) |
Mar 10 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 324.68 | 496 | 161,043 | 17,151,250 | 17.2 M to 17.2 M (0.00 %) |
Mar 10 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 323.68 | 5,962 | 1,929,802 | 17,150,754 | 17.1 M to 17.2 M (+0.03 %) |
Mar 10 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 322.98 | 2,615 | 844,600 | 17,144,792 | 17.1 M to 17.1 M (+0.02 %) |
Mar 10 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 321.89 | 5,335 | 1,717,303 | 17,142,177 | 17.1 M to 17.1 M (+0.03 %) |
Mar 10 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 320.83 | 2,116 | 678,868 | 17,136,842 | 17.1 M to 17.1 M (+0.01 %) |
Mar 10 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 319.76 | 3,284 | 1,050,088 | 17,134,726 | 17.1 M to 17.1 M (+0.02 %) |
Mar 10 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 318.27 | 2,884 | 917,886 | 17,131,442 | 17.1 M to 17.1 M (+0.02 %) |
Mar 10 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 317.18 | 3,400 | 1,078,411 | 17,128,558 | 17.1 M to 17.1 M (+0.02 %) |
Mar 10 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 316.10 | 4,398 | 1,390,195 | 17,125,158 | 17.1 M to 17.1 M (+0.03 %) |
Mar 10 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 315.22 | 5,675 | 1,788,845 | 17,120,760 | 17.1 M to 17.1 M (+0.03 %) |
Mar 10 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 314.12 | 9,206 | 2,891,794 | 17,115,085 | 17.1 M to 17.1 M (+0.05 %) |
Mar 10 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 313.11 | 12,332 | 3,861,289 | 17,105,879 | 17.1 M to 17.1 M (+0.07 %) |
Mar 10 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 312.18 | 4,295 | 1,340,800 | 17,093,547 | 17.1 M to 17.1 M (+0.03 %) |
Mar 10 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 310.98 | 2,434 | 756,934 | 17,089,252 | 17.1 M to 17.1 M (+0.01 %) |
Mar 10 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 309.89 | 3,600 | 1,115,602 | 17,086,818 | 17.1 M to 17.1 M (+0.02 %) |
Mar 10 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 308.50 | 500 | 154,251 | 17,083,218 | 17.1 M to 17.1 M (0.00 %) |
Mar 10 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 307.00 | 1,000 | 307,002 | 17,082,718 | 17.1 M to 17.1 M (+0.01 %) |
Mar 10 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 304.21 | 100 | 30,421 | 17,081,718 | 17.1 M to 17.1 M (0.00 %) |
Mar 10 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 339.82 | 65,596 | 22,290,944 | 17,081,618 | 17 M to 17.1 M (+0.39 %) |
Mar 10 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 338.64 | 14,808 | 5,014,602 | 17,016,022 | 17 M to 17 M (+0.09 %) |
Mar 07 2014 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Option Exercise | C | 0.00 | 2,700 | 0 | 0 | |
Mar 07 2014 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Buy | C | 0.00 | 2,700 | 0 | 2,700 | 0 to 2.7 K |
Mar 05 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 339.94 | 37,088 | 12,607,739 | 17,001,214 | 17 M to 17 M (+0.22 %) |
Mar 05 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 339.33 | 107,691 | 36,543,153 | 16,964,126 | 16.9 M to 17 M (+0.64 %) |
Mar 05 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 338.30 | 30,057 | 10,168,133 | 16,856,435 | 16.8 M to 16.9 M (+0.18 %) |
Mar 05 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 337.20 | 38,583 | 13,010,234 | 16,826,378 | 16.8 M to 16.8 M (+0.23 %) |
Mar 05 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 336.19 | 15,199 | 5,109,753 | 16,787,795 | 16.8 M to 16.8 M (+0.09 %) |
Mar 05 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 335.33 | 7,818 | 2,621,591 | 16,772,596 | 16.8 M to 16.8 M (+0.05 %) |
Mar 05 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 333.31 | 3,300 | 1,099,924 | 16,764,778 | 16.8 M to 16.8 M (+0.02 %) |
Mar 05 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 331.39 | 3,327 | 1,102,517 | 16,761,478 | 16.8 M to 16.8 M (+0.02 %) |
Mar 05 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 330.32 | 3,513 | 1,160,402 | 16,758,151 | 16.8 M to 16.8 M (+0.02 %) |
Mar 05 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 329.29 | 603 | 198,559 | 16,754,638 | 16.8 M to 16.8 M (0.00 %) |
Mar 05 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 328.00 | 4,415 | 1,448,113 | 16,754,035 | 16.7 M to 16.8 M (+0.03 %) |
Mar 03 2014 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Option Exercise | M | 21.92 | 4,562 | 99,999 | 0 | |
Mar 03 2014 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Option Exercise | M | 21.25 | 4,705 | 99,981 | 0 | |
Mar 03 2014 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Option Exercise | M | 20.32 | 4,921 | 99,995 | 0 | |
Mar 03 2014 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Option Exercise | M | 16.80 | 5,952 | 99,994 | 0 | |
Mar 03 2014 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Option Exercise | M | 11.64 | 8,591 | 99,999 | 0 | |
Mar 03 2014 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Option Exercise | M | 9.49 | 42,148 | 399,985 | 0 | |
Mar 03 2014 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Buy | M | 9.49 | 42,148 | 399,985 | 140,839 | 98.7 K to 140.8 K (+42.71 %) |
Mar 03 2014 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Buy | M | 11.64 | 8,591 | 99,999 | 98,691 | 90.1 K to 98.7 K (+9.53 %) |
Mar 03 2014 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Buy | M | 20.32 | 4,921 | 99,995 | 90,100 | 85.2 K to 90.1 K (+5.78 %) |
Mar 03 2014 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Buy | M | 21.92 | 4,562 | 99,999 | 85,179 | 80.6 K to 85.2 K (+5.66 %) |
Mar 03 2014 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Buy | M | 16.80 | 5,952 | 99,994 | 80,617 | 74.7 K to 80.6 K (+7.97 %) |
Mar 03 2014 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Buy | M | 21.25 | 4,705 | 99,981 | 74,665 | 70 K to 74.7 K (+6.73 %) |